Leishmaniasis: Clinical Trials

25 trials for Leishmaniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 3 not yet recruiting, 2 recruiting, 2 unknown. 25 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable25Completed 18, Not yet recruiting 3, Recruiting 2, Unknown 2

Follow Leishmaniasis: new trials by email Literature Review of Leishmaniasis trials Research Report on Leishmaniasis

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan
Virtual Reality - Cutaneous Leishmaniasis, Pain
Not applicableNot yet recruitingStanford University152027-01-012026-10-05
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases
Not applicableNot yet recruitingKenya Medical Research Institute24202026-05-012026-04-02
Human Bioequivalence Study of Liposomal Amphotericin B for Injection
Test product (Liposomal amphotericin B for injection, Sichuan Huiyu Pharmaceutical Co., Ltd.), Reference product (AmBisome®, Astellas Pharma US Inc.) - Invasive Fungal Infections, Neutropenic Fever
Not applicableCompletedSichuan Huiyu Pharmaceutical Co., Ltd582025-05-252026-05-27
Human Bioequivalence Study of Amphotericin B Liposome for Injection
Amphotericin B Liposome for Injection (strength: 50 mg, Sichuan Huiyu Pharmaceutical Co., Ltd.), Amphotericin B Liposome for Injection (trade name: Ambisome®, strength: 50 mg, MAH: Gilead Sciences) - Invasive Fungal Infections, Neutropenic Fever
Not applicableCompletedSichuan Huiyu Pharmaceutical Co., Ltd422025-05-132026-05-22
Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup
Thermotherapy - Cutaneous Leishmaniasis
Not applicableRecruitingArmauer Hansen Research Institute, Ethiopia1032025-04-242026-10-16
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Peripheral venous blood sample - Leishmaniasis, Leptospirosis
Not applicableNot yet recruitingUniversity Hospital, Montpellier1832025-03-032025-03-05
Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers
In-house Western blot, specific for Leishmania - Leishmaniasis
Not applicableRecruitingIRCCS Sacro Cuore Don Calabria di Negrar1702023-05-222024-03-12
A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies
biting by Phlebotomus duboscqi infected with Leishmania major - Leishmaniasis, Cutaneous Leishmaniases
Not applicableCompletedUniversity of York122021-10-162023-11-09
Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in Colombia
Community based strategy to follow-up pactientes with Cutaneous Leishmaniasis - Cutaneous Leishmaniasis, American
Not applicableCompletedCentro Internacional de Entrenamiento e Investigaciones Médicas1052020-03-012022-09-09
A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol
Sand fly bite - Leishmaniasis, Cutaneous, Insect Bites
Not applicableCompletedUniversity of York122019-10-032022-10-31
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
One vector feeding, Four vector feeding - Zika, Dengue
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)952018-09-052021-12-08
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
Blood sampling - Leishmaniasis, Cutaneous
Not applicableCompletedCentre Hospitalier Universitaire de Nice302017-11-102022-03-18
Improved Case Detection and Vector Control for Visceral Leishmaniasis
Inesfly Paint, IDWL (1m), ITN (KO-Tab 123) - Visceral Leishmaniasis
Not applicableCompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2022016-01-012020-01-14
Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.
Local application pentostam, intra-lisional pentostam, fractional CO2 laser - Leishmaniasis
Not applicableUnknownTel-Aviv Sourasky Medical Center202014-11-012017-01-04
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
rk28 ICT, IT LEISH (rK39), Immunochromatographic HAT test - Visceral Leishmaniasis, Human African Trypanosomiasis
Not applicableCompletedUniversity Hospital, Geneva19272013-01-012016-10-27
Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis
Herbal topical formulation - Leishmaniasis, Cutaneous
Not applicableCompletedJinnah Sindh Medical University782012-01-012021-04-12
An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Paromomycin sulfate - Visceral Leishmaniasis
Not applicableCompletedPATH1202011-01-012014-04-04
Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
N-acetylcysteine, Pentavalent antimonial - Visceral Leishmaniasis, Immune Response
Not applicableUnknownHospital Universitário Professor Edgard Santos402010-04-012010-06-08
A Community Trial for Visceral Leishmaniasis (VL)
Albendazole, Iron, Zinc and Vitamin A, Placebo - Visceral Leishmaniasis
Not applicableCompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2002009-10-012012-11-14
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
meglumine antimoniate, allopurinol, meglumine antimoniate - Leishmaniasis, Cutaneous
Not applicableCompletedCombined Military Hospital, Pakistan4002008-01-012010-06-02

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Leishmaniasis, Cutaneous (10)  ·  Leishmaniasis, Visceral (10)  ·  Brucellosis (2)  ·  Chikungunya Fever (2)  ·  Febrile Neutropenia (2)  ·  Insect Bites and Stings (2)  ·  Invasive Fungal Infections (2)  ·  Leptospirosis (2)  ·  Malaria (2)  ·  Rickettsia Infections (2)  ·  Zika Virus Infection (2)  ·  Anxiety Disorders (1)  ·  Buruli Ulcer (1)  ·  Cicatrix (1)

Broader conditions

Euglenozoa Infections (25)  ·  Infections (25)  ·  Parasitic Diseases (25)  ·  Protozoan Infections (25)  ·  Vector Borne Diseases (25)  ·  Skin Diseases (15)  ·  Skin Diseases, Infectious (15)  ·  Skin Diseases, Parasitic (15)  ·  Skin and Connective Tissue Diseases (14)  ·  Bacterial Infections and Mycoses (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Mosquito-Borne Diseases (4)  ·  Bacterial Infections (3)  ·  Chemically-Induced Disorders (3)

Interventions

Injections (2)  ·  Long-Term Synaptic Depression (2)  ·  Acetylcysteine (1)  ·  Albendazole (1)  ·  Allopurinol (1)  ·  Amphotericin B (1)  ·  Blood Specimen Collection (1)  ·  Hyperthermia, Induced (1)  ·  Iron (1)  ·  Meglumine Antimoniate (1)  ·  Paromomycin (1)  ·  Vitamin A (1)  ·  Zinc (1)  ·  liposomal amphotericin B (1)

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh (3)  ·  Hospital Universitário Professor Edgard Santos (2)  ·  Sichuan Huiyu Pharmaceutical Co., Ltd (2)  ·  University of York (2)  ·  Armauer Hansen Research Institute, Ethiopia (1)  ·  Banaras Hindu University (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Centro Internacional de Entrenamiento e Investigaciones Médicas (1)  ·  Combined Military Hospital, Pakistan (1)  ·  IRCCS Sacro Cuore Don Calabria di Negrar (1)  ·  Jinnah Sindh Medical University (1)  ·  Kenya Medical Research Institute (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  PATH (1)

Countries

Bangladesh (4)  ·  Brazil (2)  ·  China (2)  ·  Democratic Republic of the Congo (2)  ·  Ethiopia (2)  ·  France (2)  ·  India (2)  ·  Nepal (2)  ·  Pakistan (2)  ·  United Kingdom (2)  ·  Cambodia (1)  ·  Colombia (1)  ·  Italy (1)  ·  Kenya (1)  ·  Nigeria (1)

Top investigators

Charles Lacey, BMBS, MD (2)  ·  Qing Wen (2)  ·  Beena Varghese, Dr (1)  ·  Clive Davies, Dr. (1)  ·  Dinesh Mondal, PhD (1)  ·  Diwarkar Dinesh, Dr (1)  ·  Edgar M Carvalho, MD (1)  ·  Francois Chappuis, Dr. (1)  ·  Gustavo H Penaloza, PhD (1)  ·  Jean Claude Dujardin, Dr (1)

Results publications

PMID 34053461, PMID 17682988, PMID 20126269, PMID 21460008, PMID 26496648, PMID 27812090, PMID 34693027, PMID 35491421, PMID 39095597